Alkermes plc - Ordinary Shares (ALKS): Price and Financial Metrics

Alkermes plc - Ordinary Shares (ALKS): $25.05

0.63 (+2.58%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add ALKS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#36 of 348

in industry

ALKS Price/Volume Stats

Current price $25.05 52-week high $33.71
Prev. close $24.42 52-week low $22.01
Day low $24.28 Volume 2,033,000
Day high $25.18 Avg. volume 1,849,244
50-day MA $24.27 Dividend yield N/A
200-day MA $26.63 Market Cap 4.24B

ALKS Stock Price Chart Interactive Chart >


Alkermes plc - Ordinary Shares (ALKS) Company Bio


Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 and is based in Dublin, Ireland.


ALKS Latest News Stream


Event/Time News Detail
Loading, please wait...

ALKS Latest Social Stream


Loading social stream, please wait...

View Full ALKS Social Stream

Latest ALKS News From Around the Web

Below are the latest news stories about ALKERMES PLC that investors may wish to consider to help them evaluate ALKS as an investment opportunity.

Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes

Originally published in Alkermes September 2023 Corporate Responsibility Report NORTHAMPTON, MA / ACCESSWIRE / December 27, 2023 / Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive ...

Yahoo | December 27, 2023

Alkermes (ALKS) Outperforms Broader Market: What You Need to Know

Alkermes (ALKS) reachead $27.92 at the closing of the latest trading day, reflecting a +1.34% change compared to its last close.

Yahoo | December 22, 2023

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks

The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.

Yahoo | December 21, 2023

11 Most Promising Psychedelic Stocks According to Hedge Funds

In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds. If you want to skip our overview of the psychedelic industry and the latest news, then you can take a look at the 5 Most Promising Psychedelic Stocks. The ability to use chemicals to alter one’s […]

Yahoo | December 20, 2023

Corporate Governance at Alkermes

NORTHAMPTON, MA / ACCESSWIRE / December 20, 2023 / Alkermes Originally published in Alkermes September 2023 Corporate Responsibility Report Board of Directors Our Board is currently comprised of eleven members, each of whom has a term expiring at ...

Yahoo | December 20, 2023

Read More 'ALKS' Stories Here

ALKS Price Returns

1-mo 3.47%
3-mo -8.21%
6-mo -10.28%
1-year -25.51%
3-year 3.34%
5-year 10.89%
YTD -9.70%
2023 6.16%
2022 12.34%
2021 16.59%
2020 -2.21%
2019 -30.87%

Continue Researching ALKS

Want to see what other sources are saying about Alkermes plc's financials and stock price? Try the links below:

Alkermes plc (ALKS) Stock Price | Nasdaq
Alkermes plc (ALKS) Stock Quote, History and News - Yahoo Finance
Alkermes plc (ALKS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!